First immunotherapy success for triple-negative breast cancer, an aggressive type of breast cancer, as reported in the New England Journal of Medicine today.

First immunotherapy success for triple-negative breast cancer, an aggressive type of breast cancer, as reported in the New England Journal of Medicine today.: https://ift.tt/2NTlls5 Read more... https://ift.tt/2P8mL6F